Occupational asbestos exposure: how to deal with suspected mesothelioma cases--the Dutch approach

P Baas1, N van 't Hullenaar, J Wagenaar

  • 1Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. p.baas@nki.nl

Abstract

Insights

This study evaluates a Dutch system for diagnosing malignant mesothelioma (MM) in asbestos-exposed patients. The Mesothelioma Group provides expert opinions, ensuring fair compensation for occupational disease claims.

Area of Science:

  • Pulmonology
  • Occupational Health
  • Medical Diagnostics

Background:

  • Asbestos-related diseases, including malignant mesothelioma (MM), present diagnostic challenges for compensation across Europe.
  • The Netherlands utilizes the Institute of Asbestos Victims (IAV) and the Mesothelioma Group of the Dutch Thoracic Society (DTS) for patient claims.
  • Diagnostic uncertainty in MM cases necessitates specialist review.

Purpose of the Study:

  • To describe and evaluate the Dutch process for diagnosing malignant mesothelioma in patients with suspected occupational asbestos exposure.
  • To compare this diagnostic approach with practices in other European countries.

Main Methods:

  • Cases with unclear pathological confirmation of MM were reviewed by the Mesothelioma Group.
  • Diagnosis was based on clinical reports, occupational history, and imaging, with review by three independent pulmonologists.
  • A majority decision from the specialists was binding for case acceptance or rejection.

Main Results:

  • From January 2000 to May 2005, 1747 cases were submitted to the IAV.
  • 161 cases lacked definitive pathological diagnosis and were reviewed by the Mesothelioma Group.
  • 73% (117/161) of these cases were deemed compatible with malignant pleural mesothelioma, with unanimous specialist agreement in 75% of reviewed cases. The median reporting time was 34 days.

Conclusions:

  • The Dutch approach, involving the IAV and Mesothelioma Group, is an effective and efficient method for investigating claims of occupationally related malignant mesothelioma.
  • This system offers a rapid and reliable diagnostic pathway compared to other European compensation models.